Image: Everyday HealthFDA Approves New COVID-19 Vaccines for the 2026-2027 Season
• The FDA has approved new COVID-19 vaccines for the 2026-2027 season, specifically designed to target the XFG variant. • The vaccines are approved for adults aged 65 and older, with eligibility extended to younger individuals in high-risk groups depending on the specific shot. • This update is critical for maintaining immunity against evolving strains and protecting vulnerable populations during the upcoming respiratory virus season.
everydayhealth.com